PP XPhyto Related News
BioNxt makes bold move into proprietary MS drug formulation market
Leading bioscience accelerator BioNxt Solutions Inc. is pioneering a cutting-edge oral dissolvable Cladribine product for the treatment of Multiple Sclerosis (MS).
The Company recently acquired...
BioNxt acquires cutting-edge equipment to boost drug delivery product manufacturing
BioNxt Solutions Inc. has proudly announced the acquisition of advanced coating and cutting equipment, marking a crucial stride in expanding its commercial manufacturing of...
Innovation in drug delivery
We hear from Hugh Rogers of BioNxt Solutions about how the company is driving innovation in drug delivery systems that can support patients with...
Reimagining drug delivery and diagnostics
BioNxt Solutions’ Hugh Rogers explains how the company is driving forward innovation in drug delivery methods and diagnostics technology.
Canadian-headquartered life sciences company, BioNxt Solutions,...
Platform Delivery Technology: working double time for transdermal drugs and oral biosensors
XPhyto Therapeutics outlines the latest developments concerning its generic transdermal patch to support sufferers of Parkinson’s disease and discusses the commercialisation of its innovative...
XPhyto: Taking biosensors to the next level
2022 could mark a breakout year for XPhyto Therapeutics Corp. as they look at taking their rapid detection of bacterial and infectious disease technology...
How XPhyto Therapeutics could revolutionise PCR testing
Canadian life sciences start-up, XPhyto Therapeutics, explains how it is disrupting COVID-19 testing in Europe with its breakthrough PCR diagnostics technology.
Antigen testing, though it...
XPhyto Therapeutics’ biosensors: taking rapid testing to the next level
Testing for coronaviruses may soon take no more than a couple of minutes thanks to XPhyto’s enzyme-based biosensor diagnostic technology.
A Canadian-headquartered life sciences company...
3a-diagnostics biosensors: Disease detection using chewing gum
3a-diagnostics GmbH is developing a class of next-generation diagnostic tools using biosensors to optimise at-home-diagnosis as an early, self-check of diseases including COVID-19, periodontitis,...
XPhyto expands infection prevention offering with new acquisition
Lifesciences specialist XPhyto Therapeutics has recently acquired 3a Diagnostics in a bid to advance its infection-prevention solutions.
The move is the latest development in XPhyto’s...
Precise Rapid Testing: the key to reopening Germany’s economy
Following the revelation that antigen tests are increasingly inaccurate, XPhyto Therapeutics have the solution, a point-of-care PCR test that yields results in only 25...
XPhyto: Is mescaline the next big mood-modifying medicine?
Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
XPhyto’s new PCR test has potential to transform diagnostics
XPhyto Therapeutics has developed an innovative, rapid COVID-19 PCR test that has the potential to completely transform diagnostics.
Picture this pleasing scenario: you are exiting...
XPhyto: A leader in innovating psychedelic drugs
XPhyto Therapeutics Corp is exploring the role that psychedelic pharmaceutical drugs can play in combatting mental health conditions.
It’s a staggering statistic. A full 11%...
XPhyto Therapeutics celebrates a PCR testing breakthrough
XPhyto Therapeutics has announced its ability to significantly speed up testing for COVID-19 using widely available PCR equipment.
As vaccines begin to roll out in...
